Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity

COVID-19 vaccines: where we stand and challenges ahead

(2021) Guido Forni et al.   CELL DEATH AND DIFFERENTIATION

AT-527, a double prodrug of a guanosine nucleotide analog, is a potent inhibitor of SARS-CoV-2 in vitro and a promising oral antiviral for treatment of COVID-19

(2021) Steven S. Good et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

SARS-CoV-2 variants and ending the COVID-19 pandemic

(2021) Arnaud Fontanet et al.   LANCET

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

(2021) Angela Wahl et al.   NATURE

SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development

(2021) Nicholas Murgolo et al.   PLoS Pathogens

SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates

(2021) Nikolaos C. Kyriakidis et al.   npj Vaccines

New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications

(2021) Salim S. Abdool Karim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model

(2021) Jean-Sélim Driouich et al.   Nature Communications

Considerations for the Discovery and Development of 3-Chymotrypsin-Like Cysteine Protease Inhibitors Targeting SARS-CoV-2 Infection

(2021) Koen Vandyck et al.   Current Opinion in Virology

Promising anti-SARS-CoV-2 drugs by effective dual targeting against the viral and host proteases

(2021) Samia A. Elseginy et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019

(2021) Ravindra Ganesh et al.   JOURNAL OF INFECTIOUS DISEASES

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

(2020) Manli Wang et al.   CELL RESEARCH

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

(2020) Chih-Cheng Lai et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Novel, Self-Assembling Dimeric Inhibitors of Human β Tryptase

(2020) Sarah F. Giardina et al.   JOURNAL OF MEDICINAL CHEMISTRY

Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs

(2020) Sangeun Jeon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Withanone and withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells

(2020) Vipul Kumar et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

(2020) Yeming Wang et al.   LANCET

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease

(2020) Wenhao Dai et al.   SCIENCE

Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

(2020) Richard T. Eastman et al.   ACS Central Science

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

(2020) Qingxian Cai et al.   Engineering

Discovery of M Protease inhibitors encoded by SARS-CoV-2

(2020) Hui-Chen Hung et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease

(2020) Chunlong Ma et al.   CELL RESEARCH

In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy

(2020) Tian-zi Wei et al.   Chinese Journal of Integrative Medicine

Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using in silico Structure-Based Virtual Screening Approach

(2020) Shweta Choudhary et al.   Frontiers in Immunology

TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells

(2020) Dorothea Bestle et al.   Life Science Alliance

Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19

(2020) Robert L. Hoffman et al.   JOURNAL OF MEDICINAL CHEMISTRY

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

(2020) Peter W Horby et al.   LANCET

Structures and distributions of SARS-CoV-2 spike proteins on intact virions

(2020) Zunlong Ke et al.   NATURE

Effective targeting of breast cancer cells (MCF7) via novel biogenic synthesis of gold nanoparticles using cancer-derived metabolites

(2020) Sameh S. M. Soliman et al.   PLoS One

In-silico design of a potential inhibitor of SARS-CoV-2 S protein

(2020) Grijesh Jaiswal et al.   PLoS One

Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs

(2020) Zhe Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease

(2020) Lifeng Fu et al.   Nature Communications

Critical discovery and synthesis of novel antibacterial and resistance-modifying agents inspired by plant phytochemical defense mechanisms

(2020) Sameh S.M. Soliman et al.   CHEMICO-BIOLOGICAL INTERACTIONS

FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2

(2020) Ahmed Mostafa et al.   Pharmaceuticals

Reaction-Based Enumeration, Active Learning, and Free Energy Calculations To Rapidly Explore Synthetically Tractable Chemical Space and Optimize Potency of Cyclin-Dependent Kinase 2 Inhibitors

(2019) Kyle D. Konze et al.   Journal of Chemical Information and Modeling

The Advancing of Zinc Oxide Nanoparticles for Biomedical Applications

(2018) Jinhuan Jiang et al.   BIOINORGANIC CHEMISTRY AND APPLICATIONS

Enhancing the anti-gastric cancer activity of curcumin with biocompatible and pH sensitive PMMA-AA/ZnO nanoparticles

(2018) Raman Dhivya et al.   Materials Science & Engineering C-Materials for Biological Applications

Properties of Zinc Oxide Nanoparticles and Their Activity Against Microbes

(2018) Khwaja Salahuddin Siddiqi et al.   Nanoscale Research Letters

Properties of Zinc Oxide Nanoparticles and Their Activity Against Microbes

(2018) Khwaja Salahuddin Siddiqi et al.   Nanoscale Research Letters

Polyethylene glycol-coated zinc oxide nanoparticle: an efficient nanoweapon to fight against herpes simplex virus type 1

(2018) Ahmad Tavakoli et al.   Nanomedicine

Combinatorial In Silico Strategy towards Identifying Potential Hotspots during Inhibition of Structurally Identical HDAC1 and HDAC2 Enzymes for Effective Chemotherapy against Neurological Disorders

(2017) Shabir Ahmad Ganai et al.   Frontiers in Molecular Neuroscience

BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy

(2016) Mudit Chowdhary et al.   OncoTargets and Therapy

OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins

(2015) Edward Harder et al.   Journal of Chemical Theory and Computation

Serum Proteins Enhance Dispersion Stability and Influence the Cytotoxicity and Dosimetry of ZnO Nanoparticles in Suspension and Adherent Cancer Cell Models

(2015) Catherine B. Anders et al.   Nanoscale Research Letters

Multi-drug delivery nanocarriers for combination therapy

(2015) Suresh Gadde   MedChemComm

Serum Proteins Enhance Dispersion Stability and Influence the Cytotoxicity and Dosimetry of ZnO Nanoparticles in Suspension and Adherent Cancer Cell Models

(2015) Catherine B. Anders et al.   Nanoscale Research Letters

Optimization of Potent DFG-in Inhibitors of Platelet Derived Growth Factor Receptorβ (PDGF-Rβ) Guided by Water Thermodynamics

(2014) Rebecca Horbert et al.   JOURNAL OF MEDICINAL CHEMISTRY

Antiviral drugs specific for coronaviruses in preclinical development

(2014) Adeyemi O Adedeji et al.   Current Opinion in Virology

Biomedical Applications of Zinc Oxide Nanomaterials

(2013) Y. Zhang et al.   CURRENT MOLECULAR MEDICINE

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

(2013) G. Madhavi Sastry et al.   JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

Starting-structure dependence of nanosecond timescale intersubstate transitions and reproducibility of MD-derived order parameters

(2013) Tim Zeiske et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Contributions of water transfer energy to protein-ligand association and dissociation barriers: Watermap analysis of a series of p38α MAP kinase inhibitors

(2013) Robert A. Pearlstein et al.   PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS

Synthesis and characterization of doxorubicin modified ZnO/PEG nanomaterials and its photodynamic action

(2012) R. Hariharan et al.   JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY

Structure-Activity Relationships (SAR) Research of Thiourea Derivatives as Dual Inhibitors Targeting both HIV-1 Capsid and Human Cyclophilin A

(2010) Kan Chen et al.   Chemical Biology & Drug Design

Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution

(2010) Jeremy R. Greenwood et al.   JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN

Combination therapy in hypertension

(2010) Alan H. Gradman et al.   Journal of the American Society of Hypertension

Role of the Active-Site Solvent in the Thermodynamics of Factor Xa Ligand Binding

(2008) Robert Abel et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY